Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas
- Conditions
- Pancreatic Cancer
- Interventions
- Procedure: percutaneous fluoro guided celiac plexus neurolysisProcedure: EUS guided neurolysis
- Registration Number
- NCT01182831
- Lead Sponsor
- Asian Institute of Gastroenterology, India
- Brief Summary
Coeliac plexus neurolysis (CPN) is a management option for pain control in carcinoma pancreas.CPN is conventionally performed by percutaneous technique with fluoroscopic guidance. Endoscopic ultrasound (EUS) is increasingly used for CPN as it offers a better visualization of the plexus. There are limited data comparing the two modalities.The patients are on follow-up for 6 months post neurolysis.
- Detailed Description
Carcinoma pancreas patients with abdominal pain requiring daily analgesics for more than 4 weeks were included.we are randomising about 100 patients into two groups to undergo either of the two procedures, i.e. celiac plexus neurolysis by percutaneous technique or by endoscopic ultrasound guided technique.The pain scores have been recorded by visual analogue scale for an average follow-up of 6 months.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- all patients with carcinoma pancreas
- patients below 18 years of age and who have not given consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description percutaneous fluoro guided celiac plexus neurolysis percutaneous fluoro guided celiac plexus neurolysis - EUS guided neurolysis EUS guided neurolysis -
- Primary Outcome Measures
Name Time Method immediate pain relief day of block to six months of follow-up
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Asian Institute of Gastroenterology
🇮🇳Hyderabad, Andhra pradesh, India